Navigation Links
Cheetah Medical Announces New Management Team
Date:6/4/2013

NEWTON, Mass., June 4, 2013 /PRNewswire/ -- Cheetah Medical Inc., which developed and markets NICOM®, the revolutionary Non-invasive Hemodynamic Monitoring System, today announced the appointment of Chris Hutchison as President and CEO and William T. Denman , MBChB, FRCA as Chief Medical Officer.  Concurrently, the Company announced the completion of a $14.5 million financing with a prestigious group of investors including Springfield Investments, Ascension Health Ventures, MVM Life Science Partners and Robert Bosch Venture Capital.

The proceeds will be used to accelerate commercialization of NICOM in the U.S. and internationally.  NICOM is currently deployed for Goal Directed Fluid Management in over 100 hospitals in the U.S. and is widely used in OUS markets.

Mr. Hutchison has spent over 25 years in the medical device industry and has extensive general management experience, including commercializing early stage technologies in the U.S., Europe and Emerging Markets.  Prior to Cheetah he spent seven years with Covidien where he served as a General Manager in the Respiratory & Monitoring Systems and Vascular Therapies divisions.  Prior to joining Covidien, Mr. Hutchison was a U.S. Divisional President at Smiths Medical.

"There is a real need in many hospital settings for early, accurate and non-invasive hemodynamic information to better inform clinical decision making.  Since it is noninvasive, NICOM is easy and quick to deploy in critical care settings and eliminates many risks associated with older invasive methods.  He continued, "We believe that NICOM improves patient outcomes, and drives favorable healthcare economics, both of which are key considerations in the current healthcare environment."

"I am pleased to have "Pepper" Denman as our Chief Medical Officer.  He has had a distinguished career as a clinician specializing in anesthesiology, as a researcher, as an Assistant Professor at the Harvard Medical School, and was a healthcare executive for over nine years with Covidien and GE Healthcare.  He has a broad knowledge of fluid management and the critical role that it plays in patient care.

About Cheetah Medical
Cheetah Medical's NICOM Noninvasive Hemodynamic Monitoring System is based on the Company's patented and proprietary BIOREACTANCE® technology.  Clinicians use the NICOM for noninvasive, Goal Directed Fluid Management in critical and non-critical clinical environments.  NICOM is FDA cleared and has received a CE Mark.

Founded in 2000, Cheetah medical is privately held and is headquartered in Vancouver, WA.  For more information about Cheetah Medical, please visit our website at www.cheetah-medical.com.Company Contact: Media Contact:Jim Wagner

Steve Sandler(617) 947-8946

(508) 358-7206 ext. 202jim.wagner@cheetah-medical.comssandler@vmark.net


'/>"/>
SOURCE Cheetah Medical Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. seca Launches the seca mBCA 514 - medical Body Composition Analyzer
2. Kettering Medical Center Acquires Elektas Versa HD Radiotherapy System
3. Solta Medical Announces Isolaz 2 Acne System
4. Pioneering Medical Technology Company, Optivus Proton Therapy, Inc., Celebrates 20th Anniversary
5. Cantel Medical Corp. To Hold Conference Call To Discuss Results for Its Third Quarter Ended April 30, 2013
6. Vanda to Present Tasimelteon Non-24 Phase III Data at Two Medical Meetings
7. CCS Medical Announces Enhanced Product Formulary
8. ViewRays Chief Medical Officer Honored by American Society for Radiation Oncology (ASTRO)
9. Hair Restoration Center Announces New Female Medical Hair Restoration
10. Kite Pharma Appoints Keith Nolop, M.D. Chief Medical Officer
11. Medical Device & Implants, LLC to exhibit at MD&M East 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... , Feb. 8, 2016  Sangamo BioSciences, Inc. ... genome editing, announced that the U.S. Food and ... New Drug (IND) application for SB-318, a single ... for Mucopolysaccharidosis Type I (MPS I). The SB-318 ... to initiate a Phase 1/2 clinical study (SB-318-1502) ...
(Date:2/8/2016)... , February 8, 2016 ... new report published by Allied Market Research titled, ... Opportunities and Forecasts, 2014-2020", estimates the world synthetic ... Nucleotide synthesis and sequencing technology segment would continue ... and software tools segment, collectively, held around half ...
(Date:2/8/2016)... , 8. Februar 2016  LivaNova, PLC, ... eine Infografik mit dem Titel „Epilepsy Around ... mit der der Krankheit gegenüber ein größeres ... ermutigen soll, Medikamentenresistenz bei Epilepsie auf dem ... Diskussion zu machen. Mithilfe der neuen Infografik ...
Breaking Medicine Technology:
(Date:2/8/2016)... ... 08, 2016 , ... Local insurance agency Dennis Fuller & ... has initiated a fundraiser for a two year old little girl named Bella, ... To support this beautiful child who is facing life’s journey without her loving ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... networking and relationship-marketing firm, announced today that nominations will be accepted February ... (ISE®) West Awards. , Awards include the Information Security Executive® of ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... frequently. While a significant number of women and men with eating disorders report ... itself, that best predicts the development of an eating disorder. , At ...
(Date:2/8/2016)... ... 2016 , ... Discover the Rocky Mountain region’s longest running and impressive garden ... Attendees also get to see the most incredible gardens and home improvement experts that ... the Colorado Convention Center - 700 14th St. Denver CO, is an exciting event ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... share this important news! AHCC and the Home Health and Hospice ICD-10 Transition ... designee for official ICD coding guidance and clarifications, to address concerns over the ...
Breaking Medicine News(10 mins):